Connecting Japanese technologies to Indian clinical skills. Interview broadcasted in Thanthi TV (Tamil)
The interview explains the potential synergy between India and Japan; with technically qualified manpower India has, if the hi-tech technologies of Japan could come together, that will yield several solutions not only to both the countries but to the global society as earlier demonstrated by the GN Corp-NCRM-MediNippon team of Tissue engineering basic technology in cornea which yielded novel cell therapy technology for male urethral stricture which through Indo-Japan collaboration was later tech-transferred from India to Japan one of the first of its kind in the history.
🎥 Watch the interview:
https://t.co/5yaqGjKhtv
📷YouTube
#IndoJapan #RegenerativeMedicine #CellTherapy #TechnologyTransfer #Innovation #Healthcare #TissueEngineering #ClinicalTranslation #MedicalResearch #GNCorporation #NCRM #MediNippon #GlobalHealthcare #ThanthiTV #Collaboration #ScienceForSociety
Vibes well with what Dr.K.M.Cherian said in 2005 "Hospitals would be called, Centres of regeneration" during NCRM inauguration. Today we have been able to place in records, few significant steps in that direction viz., In vitro reversal of aging (senescence) of worn out human chondrocytes (https://t.co/206ivSTEUa), Successful repair or damaged urothelium by transplanted cells with clinical proof of engraftment (https://t.co/kCzE7q1wJT), Restoration of human corneal endothelium in patients with bullous keratopathy supported by a novel nanocomposite scaffold (https://t.co/hwXyvByS1h).. to mention a few.,
As we recently celebrated the birthday of Prof. Yoshikazu Kurosawa, the most significant contribution everyone reminisced was his publication in 1981 in Nature titled “Identification of D segments of immunoglobulin heavy-chain genes and their rearrangement in T lymphocytes” (https://t.co/QhXqfaVqmK) which was gratefully acknowledged by Prof. Susumu Tonegawa in his Nobel Prize for Medicine Lecture, in 1987 (https://t.co/LCwm90wTuB).
Subsequently, we recollected his visit to NCRM, Chennai, India (https://t.co/0q2PyorCR8) in 2010 and his lecture on “Antibody based novel approach to cancer treatment, Present and Future” which was organized by Dr. Pushkala Subramanian, the present Vice Chancellor of The Tamil Nadu Dr MGR Medical University, who was then the Professor and Head of the Department of Immunology.
Time flies, Memories remain; Thanks to Dr. Gene Kurosawa for joining us, as he ceaselessly pursues advanced research on the footsteps of Prof. Yoshikazu Kurosawa on antibody based approaches to manage emerging infectious diseases. Miles to Go before we sleep! @infdisease_news@Antibodies_MDPI@NobelPrize@NobelPeaceOslo@ImmunologyAAI@ImmunoPodcast@ImmunityCP@immunedeficienC@UHN@FHU_PR@Immune_News #ncrm #immunology #nobelprize #antibodies #mab
>> 再生医療における画期的なBEES-HAUS細胞療法(パラクリン効果と細胞の定着による尿道狭窄症治療)を簡略化したBHES-HAUSの臨床結果をAUA 2026で発表 (https://t.co/dawf05GoZc)
>> Un'impresa pionieristica nel campo della medicina rigenerativa: la terapia cellulare BEES-HAUS: effetto paracrino e attecchimento cellulare consentono assieme di guarire la stenosi uretrale. I risultati della versione semplificata BHES-HAUS ...
>> Avance pionero en medicina regenerativa, la terapia celular BEES-HAUS: El efecto paracrino y el injerto celular se combinan para reparar la estenosis uretral. Los resultados de su versión simplificada, BHES-HAUS, se presentarán en la AUA 2026
>> Eine bahnbrechende Leistung in der regenerativen Medizin: die BEES-HAUS-Zelltherapie – parakriner Effekt und Zellansiedlung heilen gemeinsam die Harnröhrenstriktur. Die Ergebnisse der vereinfachten Version, BHES-HAUS, werden auf der AUA 2026 ...
>> Une avancée majeure en médecine régénérative, la thérapie cellulaire BEES-HAUS : effet paracrine et prise de greffe cellulaire, deux mécanismes qui, combinés, permettent de soigner la sténose urétrale. Les résultats de sa version simplifiée, ...
>> 再生医学的重大突破BEES-HAUS细胞疗法:旁分泌效应与细胞嫁接,以及修复尿道狭窄。其简化版BHES-HAUS的结果将在AUA 2026上发布
அடேய்களா
இருக்க கடுப்புல நீங்க வேற இப்போ தேர்தல் நடந்தால் யாருக்கு ஓட்டு போடுவிங்க
நான் திமுக காரன் சொல்றவன் மட்டும் RT பண்ணுங்க னு
தாலிய அருக்காதீங்க டா 🙏🙏😭
ஒட்டுமொத்த உலகமே தமிழ்நாட்டை பெருமையாக பார்த்தது.. ஆனால் இன்று கேவலமாக பார்க்கிறது. இந்த பெருமை தற்குறி விஜய்யவே சேரும்..... 🤦🤦🤦
#BlackDay_For_TamilNadu
ஒரு பதிவில் நமது தலைவர்
@mkstalin அவர்களை முன்னாள் முதல்வர் என்று பதிவு செய்திருந்தேன்
அப்பதிவில் ஒரு நண்பர் முன்னாள் முதல்வர் என்று அழைப்பதை விட
#மக்களின்_முதல்வர் என்று அழைப்பது நன்றாக இருக்கும் என்று சொன்னார்
இனிமேல் நமது தலைவரை
#மக்களின்_முதல்வர் என அன்புடன் அழைப்போம்
Congratulations Kavya & Pradeepa! Winners of the 20th Edition of Fujio Cup Quiz on stem cells and regenerative
Medicine @NCRM NICHE 2025, representing Sri Ramachandra Institute of Higher Education & Research, India. Sincere appreciations to the runners Anirudh & Ravisagar (Ramaiah Institute of Technology), Jeothilashmi& Keerthana (Rajalakshmi Engineering College) & the special presentation invitees Dean & David (St.JosephUniversity, Tanzania). We all learned intricacies and dynamics of cell biology, translational path from bench to bedside and most importantly on the significance of inter-disciplinary research through three stages of the toughly fought contest among 60 teams from four countries that witnessed the grand finale yesterday commemorating the 20th inaugural anniversary of Nichi-in Centre for Regenerative Medicine, now with R&D center in Mauritius, in collaboration with Soul Synergy. Thanking all the participants, our collaborators, invited speakers and the jury. @NcrmNiche@SRIHER_Official@TheHinduScience@TOIIndiaNews@TOIChennai@TheHindu@IndianExpress@InterdiscipBiol@weareLIS@wildfirecenter@NCRM@StemCellNetwork @fujiocupquiz #fujiocupquiz #ncrm #ncrmniche #sriher #regenerativemedicine #stemcells #celltherapy
Chennai population’s healthcare indices indicate an early onset of immune-aging; Associated risks of Diabetes & metabolic syndrome to be addressed by preventive measures -presented at 54th Annual meeting of ISEH, Kumamoto, Japan. “As per the study results, the mean NLR in the studied urban Chennai population was found to be greater than 2.0, which is higher than other globally reported population studies. This suggests that preventive strategies must be initiated early, ideally from the late 20’s to ensure healthy aging and reduce the burden of diabetes, cardiac, and metabolic diseases”, opined Dr. C. J. Vetrievel, Chairman of BeWellHospitals, the lead author of the study. He also added that a comparative evaluation of similar biomarkers in HIV+vepatients which was done in collaboration with the National AIDS Secretariat in Mauritius has revealed that the marker we have checked is highly relevant to the strength of immune system and is significant in assessing one’s health for planning preventive strategies. https://t.co/d3UhDJ1Hw4 @BeWellHospitals@NaturallyFTW@NatRevImmunol@NatImmunol@ImmunologyAAI@ISEHSociety #bewellhospital #iseh #chennai #preventivehealth #immunity #publichealth #hiv #mauritius
Unless the hostile environment with inflammation is kept under control, treatment approaches to manage Duchenne Muscular Dystrophy may not yield the expected outcome. In our paper titled "Improving the therapeutic efficacy of gene therapy for duchenne muscular dystrophy (DMD) by evaluating and managing inflammation" (https://t.co/f6dsRh8Lx5) we describe how the Neu REFIX Beta 1,3-1,6 glucan could help achieve the goals of gene therapy for DMD based on its safe and beneficial anti-inflammatory and anti-fibrotic efficacies (https://t.co/FWnWPY6xo8) yielding enhancement of muscle regeneration markers (https://t.co/Ozxe1wYmlA) and improvement of plasma dystrophin in a clinical trial (https://t.co/JyKPKRLkyY). Having been granted Orphan drug designation (ODD) and Rare pediatric disease designation (https://t.co/iYFlQcjbHs), this food supplement is worth considering as an adjuvant by those who would like to value add to their drug candidate for DMD. Our journey of 14 years to this discovery is in: https://t.co/6m3phSTvI6. @DuchenneUK@Sarepta@GeneTherapy_SN@genetherapynet@MuscularDystrop@MDAorg
@ConsortiumNLUs The CLAT entrance exam is scheduled for 1st December, but severe flooding in Chennai has disrupted transportation. Kindly consider rescheduling or providing alternate arrangements. 🙏
#ChennaiRains
📢 Urgent Appeal: The CLAT entrance exam is scheduled for 1st December, but severe flooding in Chennai has disrupted transportation. Kindly consider rescheduling or providing alternate arrangements. 🙏
@CLATConsortium @mkstalin@ugc_india#CLAT2024#ChennaiFloods